EPAC vs TECH · P/E 24, rev $616.9M vs P/E 65, rev $1.22B
Enerpac Tool Group Corp (EPAC) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Enerpac Tool Group Corp (EPAC) is a specialty industrial machinery company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported EPAC revenue for 2025-08-31 was $616.9M. Net income was $92.7M. Revenue was up 4.6% from 2024-08-31 to 2025-08-31. EPAC currently screens at market cap $2.06B and trailing P/E 23.7.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
EPAC currently screens at market cap $2.06B and trailing P/E 23.7. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the EPAC and TECH stock pages for the full models.
Not investment advice.